Cite
Safety of long-term treatment of HAM/FSP patients with valproic acid.
MLA
Olindo, Stéphane, et al. “Safety of Long-Term Treatment of HAM/FSP Patients with Valproic Acid.” Blood, vol. 118, no. 24, Dec. 2011, pp. 6306–09. EBSCOhost, https://doi.org/10.1182/blood-2011-04-349910.
APA
Olindo, S., Belrose, G., Gillet, N., Rodriguez, S., Boxus, M., Verlaeten, O., Asquith, B., Bangham, C., Signate, A., Smadja, D., Lezin, A., Césaire, R., & Willems, L. (2011). Safety of long-term treatment of HAM/FSP patients with valproic acid. Blood, 118(24), 6306–6309. https://doi.org/10.1182/blood-2011-04-349910
Chicago
Olindo, Stéphane, Gildas Belrose, Nicolas Gillet, Sabrina Rodriguez, Mathieu Boxus, Olivier Verlaeten, Becca Asquith, et al. 2011. “Safety of Long-Term Treatment of HAM/FSP Patients with Valproic Acid.” Blood 118 (24): 6306–9. doi:10.1182/blood-2011-04-349910.